Provista Diagnostics Inc., a relatively young New York-based company, is looking to help patients with abnormal or difficult-to-interpret mammograms with its Videssa Breast assay. To that end, the company recently completed a 28 state pilot commercialization program, with an eye toward a larger launch through strategic partners. Read More
